Using human induced pluripotent stem cells to model cerebellar disease: Hope and hype

Sarah WiethoffNational Hospital for Neurology and Neurosurgery, UCL Institute of Neurology, London, UK;Center for Neurology and Hertie Institute for Clinical Brain Research, Eberhard-Karls-University, Tübingen, GermanyCorrespondence[email protected] [email protected]

Charles ArberDepartment of Molecular Neuroscience and Queen Square Brain Bank, UCL Institute of Neurology, London, UK

Abi LiDepartment of Molecular Neuroscience and Queen Square Brain Bank, UCL Institute of Neurology, London, UK

Selina WrayDepartment of Molecular Neuroscience and Queen Square Brain Bank, UCL Institute of Neurology, London, UK

Henry HouldenNational Hospital for Neurology and Neurosurgery, UCL Institute of Neurology, London, UK

Rickie PataniNational Hospital for Neurology and Neurosurgery, UCL Institute of Neurology, London, UK;Department of Molecular Neuroscience and Queen Square Brain Bank, UCL Institute of Neurology, London, UK;Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK;Euan MacDonald Centre for MND, University of Edinburgh, Edinburgh, UKCorrespondence[email protected] [email protected]

Using human induced pluripotent stem cells to model cerebellar disease: Hope and hype

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Using human induced pluripotent stem cells to model cerebellar disease: Hope and hype

Reprints and Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date